Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
Arginine Depletion with DFMO in High-Risk Neuroblastoma |
Children’s Hospital of Philadelphia / Christina Turn, MD |
Young Investigator Grants |
2023 |
Pennsylvania |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children’s Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma |
Duke University / Michael Armstrong |
Young Investigator Grants |
2011 |
North Carolina |
E2A translocations in pediatric leukemia: developing new therapeutic targets
|
Children’s Hospital of Philadelphia / Bruce Fischer, MD |
Young Investigator Grants |
2007 |
Pennsylvania |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD |
Young Investigator Grants |
2014 |
Washington |
Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia |
University of Pennsylvania / Kelly Getz, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Melinda Biernacki, MD |
Young Investigator Grants |
2016 |
Washington |
Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma |
Seattle Children’s Hospital / Shireen Ganapathi, MD |
Young Investigator Grants |
2021 |
Washington |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |